康龙化成(03759)拟折让约8.50%配售总计5844.08万股 净筹约13.19亿港元
智通财经网·2026-01-14 22:48

Group 1 - The company, 康龙化成, announced a placement agreement with placement agents to issue a total of 58.4408 million new H-shares at a price of HKD 22.82 per share, representing a discount of approximately 8.50% from the market price of HKD 24.94 on January 14, 2026 [1] - The total expected proceeds from the placement are approximately HKD 1.334 billion, with a net amount of about HKD 1.319 billion after expenses [1] - The proceeds will be allocated as follows: approximately 70% for project construction to enhance laboratory services, drug process development, and production capacity; about 10% for repaying bank loans and other borrowings to optimize the capital structure; and around 20% for working capital and other general corporate purposes [1]

PHARMARON-康龙化成(03759)拟折让约8.50%配售总计5844.08万股 净筹约13.19亿港元 - Reportify